<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39496842</PMID><DateCompleted><Year>2024</Year><Month>11</Month><Day>04</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>06</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Nov</Month><Day>04</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Presence of COVID-19 self-reported symptoms at 12 months in patients discharged from hospital in 2020-2021: a Spanish cross-sectional study.</ArticleTitle><Pagination><StartPage>26575</StartPage><MedlinePgn>26575</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">26575</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-024-78017-x</ELocationID><Abstract><AbstractText>The long-term effects of SARS-CoV-2 infection, and their determinants, are still unknown. This study aimed to assess symptoms one year after admission for COVID-19, according to the organ/system involved, and to identify factors. Cross-sectional study with retrospective data collection from March 2020 to February 2021. Inclusion criteria: aged&#x2009;&#x2265;&#x2009;18 years and admitted for COVID-19. Exclusion criteria: death, not localized, refusal to participate, cognitive impairment or language barrier. A telephone survey was conducted on long COVID-related symptoms one year after hospital discharge. n&#x2009;=&#x2009;486. The most frequent symptom groups were neurological (n&#x2009;=&#x2009;225; 46.3%) and respiratory (n&#x2009;=&#x2009;201; 41.4%). Multivariable analysis showed that a history of anxiety was significantly associated with psychiatric symptoms (ORa&#x2009;=&#x2009;2.04, 95%CI&#x2009;=&#x2009;1.02-4.06), fibromyalgia/chronic fatigue with general symptoms (ORa&#x2009;=&#x2009;11.59, 95%CI&#x2009;=&#x2009;1.47-9.34) and obesity with respiratory (ORa 1.90, 95%CI&#x2009;=&#x2009;1.27-2.83) and musculoskeletal symptoms (ORa 1.96, 95%CI&#x2009;=&#x2009;1.30-2.96). Male sex was associated with a significantly lower risk of neurological (ORa 0.64, 95%CI&#x2009;=&#x2009;0.44-0.93), respiratory (ORa 0.45, 95%CI&#x2009;=&#x2009;0.31-0.67), general (ORa 0.43, 95%CI&#x2009;=&#x2009;0.29-0.63), psychiatric (ORa 0.34, 95%CI&#x2009;=&#x2009;0.22-0.51), musculoskeletal (ORa 0.47, 95%CI&#x2009;=&#x2009;0.32-0.70), dermatological (ORa 0.24, 95%CI&#x2009;=&#x2009;0.14-0.42) and digestive (ORa 0.38, 95%CI&#x2009;=&#x2009;0.20-0.73) symptoms. Advanced age (&#x2265;&#x2009;71 years) also had a protective effect against general (ORa 0.60, 95%CI&#x2009;=&#x2009;0.39-0.95), psychiatric (ORa 0.39, 95%CI&#x2009;=&#x2009;0.23-0.64), and dermatological (ORa 0.47, 95%CI&#x2009;=&#x2009;0.24-0.92) symptoms. Patients admitted for SARS-CoV-2 infection frequently experience symptoms at one year, especially neurological and respiratory symptoms. Female sex, obesity, a history of anxiety and fibromyalgia/chronic fatigue were independent risk factors for presenting symptoms. Advanced age acted as a protective factor.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>P&#xe9;rez Catal&#xe1;n</LastName><ForeName>Ignacio</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Internal Medicine Service, University General Hospital of Castellon, Castell&#xf3;n de la Plana, Spain. nachocs13@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Roig Mart&#xed;</LastName><ForeName>Celia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Internal Medicine Service, University General Hospital of Castellon, Castell&#xf3;n de la Plana, Spain. celia.roig.marti@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Folgado Escudero</LastName><ForeName>Sof&#xed;a</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Internal Medicine Service, University General Hospital of Castellon, Castell&#xf3;n de la Plana, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Segura F&#xe1;brega</LastName><ForeName>Ana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Internal Medicine Service, University General Hospital of Castellon, Castell&#xf3;n de la Plana, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Varea Villanueva</LastName><ForeName>Mar&#xed;a</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Internal Medicine Service, University General Hospital of Castellon, Castell&#xf3;n de la Plana, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fabra Juana</LastName><ForeName>Sergio</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Internal Medicine Service, University General Hospital of Castellon, Castell&#xf3;n de la Plana, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dom&#xed;nguez Bajo</LastName><ForeName>Elena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Internal Medicine Service, University General Hospital of Castellon, Castell&#xf3;n de la Plana, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Herrero Rodr&#xed;guez</LastName><ForeName>Germ&#xe1;n</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Internal Medicine Service, University General Hospital of Castellon, Castell&#xf3;n de la Plana, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Esteve Gimeno</LastName><ForeName>Mar&#xed;a Jos&#xe9;</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Internal Medicine Service, University General Hospital of Castellon, Castell&#xf3;n de la Plana, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Palomo de la Sota</LastName><ForeName>Daniela</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Internal Medicine Service, Hospital of Vinaroz, Vinaroz, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cardenal &#xc1;lvarez</LastName><ForeName>Alejandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Internal Medicine Service, Hospital of Mendaro, Mendaro, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mateu Campos</LastName><ForeName>Mar&#xed;a Lid&#xf3;n</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Intensive Care Unit, University General Hospital of Castellon, Castell&#xf3;n de la Plana, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Us&#xf3; Blasco</LastName><ForeName>Jorge</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Internal Medicine Service, University General Hospital of Castellon, Castell&#xf3;n de la Plana, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Ramos Rinc&#xf3;n</LastName><ForeName>Jose Manuel</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Internal Medicine Service, University General Hospital of Alicante, Alicante, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>11</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013030" MajorTopicYN="N" Type="Geographic">Spain</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010351" MajorTopicYN="Y">Patient Discharge</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057566" MajorTopicYN="Y">Self Report</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001007" MajorTopicYN="N">Anxiety</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Fatigue</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Post-acute COVID-19 syndrome</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>5</Day><Hour>0</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>5</Day><Hour>0</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>4</Day><Hour>23</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>11</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39496842</ArticleId><ArticleId IdType="doi">10.1038/s41598-024-78017-x</ArticleId><ArticleId IdType="pii">10.1038/s41598-024-78017-x</ArticleId><ArticleId IdType="pmc">PMC11535462</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Coronavirus Resource Center. (2023). https://coronavirus.jhu.edu/map.html (accedido Enero 11, 2024).</Citation></Reference><Reference><Citation>Gandhi, R. T., Lynch, J. B. &amp; Del Rio, C. Mild or moderate Covid-19. N Engl. J. Med.383 (18), 1757&#x2013;1766. 10.1056/NEJMcp2009249 (2020). Epub 2020 Apr 24.</Citation><ArticleIdList><ArticleId IdType="pubmed">32329974</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanson, S. W. et al. A global systematic analysis of the occurrence, severity, and recovery pattern of long COVID in 2020 and 2021. medRxiv [Preprint]. (2022). 10.1101/2022.05.26.22275532</Citation></Reference><Reference><Citation>World Health Organization. A clinical case definition of post COVID-19 condition by a Delphi consensus. (2021). https://www.who.int/publications-detail-redirect/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1 (Accedido Enero 11, 2024).</Citation></Reference><Reference><Citation>Logue, J. K. et al. Sequelae in adults at 6 months after COVID-19 infection. JAMA Netw. Open.4, e210830. 10.1001/jamanetworkopen.2021.0830 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7896197</ArticleId><ArticleId IdType="pubmed">33606031</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigfrid, L. et al. Long covid in adults discharged from UK hospitals after Covid-19: a prospective, multicentre cohort study using the ISARIC WHO clinical characterisation protocol. Lancet Reg. Health Eur.8, 100186. 10.1016/j.lanepe.2021.100186 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8343377</ArticleId><ArticleId IdType="pubmed">34386785</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang, C. et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 397, 220&#x2013;232. 10.1016/S0140-6736(20)32656-8 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang, L. et al. Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study. Lancet Respir Med.10, 863&#x2013;876. 10.1016/S2213-2600(22)00126-6 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9094732</ArticleId><ArticleId IdType="pubmed">35568052</ArticleId></ArticleIdList></Reference><Reference><Citation>Global Burden of Disease Long COVID Collaborators et al. Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021. JAMA. 328:1604&#x2013;15. doi: (2022). 10.1001/jama.2022.18931</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9552043</ArticleId><ArticleId IdType="pubmed">36215063</ArticleId></ArticleIdList></Reference><Reference><Citation>Kedor, C. et al. A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity. Nat Commun. ;13(1):5104. doi: (2022). 10.1038/s41467-022-32507-6. (Erratum in: Nat Commun. 2022;13(1):6009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9426365</ArticleId><ArticleId IdType="pubmed">36042189</ArticleId></ArticleIdList></Reference><Reference><Citation>Larsen, N. W. et al. Characterization of autonomic symptom burden in long COVID: a global survey of 2,314 adults. Front. Neurol.13, 1012668. 10.3389/fneur.2022.1012668 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9639503</ArticleId><ArticleId IdType="pubmed">36353127</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;rez Catal&#xe1;n, I. et al. One-year quality of life among post-hospitalization COVID-19 patients. Front. Public. Health. 11, 1236527. 10.3389/fpubh.2023.1236527 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10588695</ArticleId><ArticleId IdType="pubmed">37869178</ArticleId></ArticleIdList></Reference><Reference><Citation>Salmon, D. et al. Long COVID patients continue to experience significant symptoms at 12 months and factors associated with improvement: a prospective cohort study in France (PERSICOR). Int. J. Infect. Dis.10.1016/j.ijid.2023.11.038 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">38141960</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran, V. T., Porcher, R., Pane, I. &amp; Ravaud, P. Course of post COVID-19 disease symptoms over time in the ComPaRe long COVID prospective e-cohort. Nat. Commun.13 (1), 1812. 10.1038/s41467-022-29513-z (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8983754</ArticleId><ArticleId IdType="pubmed">35383197</ArticleId></ArticleIdList></Reference><Reference><Citation>Bull-Otterson, L. Post&#x2013;COVID conditions among adult COVID-19 survivors aged 18&#x2013;64 and &#x2265;&#x2009;65 years &#x2014; United States, March 2020&#x2013;November 2021. MMWR Morb Mortal. Wkly. Rep.71, 713 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9368731</ArticleId><ArticleId IdType="pubmed">35925799</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban, F. et al. Fatigue and cognitive impairment in Post-COVID-19 syndrome: a systematic review and meta-analysis. Brain Behav. Immun.101, 93&#x2013;135. 10.1016/j.bbi.2021.12.020 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8715665</ArticleId><ArticleId IdType="pubmed">34973396</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis, H. E. et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 38, 101019. 10.1016/j.eclinm.2021.101019 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Spudich, S. &amp; Nath, A. Nervous system consequences of COVID-19. Science. 375(6578), 267&#x2013;269 (2022). 10.1126/science.abm2052.</Citation><ArticleIdList><ArticleId IdType="pubmed">35050660</ArticleId></ArticleIdList></Reference><Reference><Citation>Lau, B. et al. Physical and mental health disability associated with long-COVID: baseline results from a US nationwide cohort. medRxiv. 10.1016/j.amjmed.2023.08.009 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10924070</ArticleId><ArticleId IdType="pubmed">37690503</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis, H. E., McCorkell, L., Vogel, J. M., Topol, E. J. &amp; Long, C. O. V. I. D. Major findings, mechanisms and recommendations. Nat. Rev. Microbiol.21 (3), 133&#x2013;146. 10.1038/s41579-022-00846-2 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai, J. et al. A one-year follow-up study of systematic impact of long COVID symptoms among patients post SARS-CoV-2 omicron variants infection in Shanghai, China. Emerg. Microbes Infect.12 (2), 2220578. 10.1080/22221751.2023.2220578 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10281439</ArticleId><ArticleId IdType="pubmed">37272336</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, L. et al. Undiagnosed long COVID-19 in China among non-vaccinated individuals: identifying persistent symptoms and impacts on patients&#x2019; Health-Related Quality of Life. J. Epidemiol. Glob Health. 12 (4), 560&#x2013;571. 10.1007/s44197-022-00079-9 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9702954</ArticleId><ArticleId IdType="pubmed">36434150</ArticleId></ArticleIdList></Reference><Reference><Citation>Anastasio, F. et al. Medium-term impact of COVID-19 on pulmonary function, functional capacity and quality of life. Eur. Respir J.58 (3), 2004015. 10.1183/13993003.04015-2020 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7877327</ArticleId><ArticleId IdType="pubmed">33574080</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian, A. et al. Symptoms and risk factors for long COVID in non-hospitalized adults. Nat. Med.28 (8), 1706&#x2013;1714. 10.1038/s41591-022-01909-w (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>Dessie, Z. G. &amp; Zewotir, T. Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patients. BMC Infect. Dis.21 (1), 855. 10.1186/s12879-021-06536-3 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8380115</ArticleId><ArticleId IdType="pubmed">34418980</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu, Q. et al. Follow-up of patients with COVID-19 by the Delta variant after hospital discharge in Guangzhou, Guandong, China. Rev. Inst. Med. Trop. Sao Paulo. 64, e31. 10.1590/S1678-9946202264031 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9084466</ArticleId><ArticleId IdType="pubmed">35544909</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani, D. et al. Risk of long COVID in people infected with severe Acute Respiratory Syndrome Coronavirus 2 after 2 doses of a Coronavirus Disease 2019 Vaccine: Community-Based, matched Cohort Study. Open. Forum Infect. Dis.9 (9), ofac464. 10.1093/ofid/ofac464 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9494414</ArticleId><ArticleId IdType="pubmed">36168555</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly, Z., Bowe, B. &amp; Xie, Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat. Med.28 (7), 1461&#x2013;1467. 10.1038/s41591-022-01840-0 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9307472</ArticleId><ArticleId IdType="pubmed">35614233</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao, P., Liu, J. &amp; Liu, M. Effect of COVID-19 vaccines on reducing the risk of long COVID in the Real World: a systematic review and Meta-analysis. Int. J. Environ. Res. Public. Health. 19 (19), 12422. 10.3390/ijerph191912422 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9566528</ArticleId><ArticleId IdType="pubmed">36231717</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi, B. C. &amp; Pak, A. W. A catalog of biases in questionnaires. Prev. Chronic Dis.2 (1), A13 (2005). (Epub 2004 Dec 15. PMID: 15670466; PMCID: PMC1323316).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1323316</ArticleId><ArticleId IdType="pubmed">15670466</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>